Tau, ADNP, and sex.

Amram, N., Hacohen-Kleiman, G., Sragovich, S., Malishkevich, A., Katz, J., Touloumi, O., Lagoudaki, R., Grigoriadis, N. C., Giladi, E., Yeheskel, A., Pasmanik-Chor, M., Jouroukhin, Y., & Gozes, I. (2016). Sexual divergence in microtubule function: The novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory. Molecular Psychiatry, 21, 1467-1476. https://doi.org/10.1038/mp.2015.208

Barthelemy, N. R., Liu, H., Lu, W., Kotzbauer, P. T., Bateman, R. J., & Lucey, B. P. (2020). Sleep deprivation affects tau phosphorylation in human cerebrospinal fluid. Annals of Neurology, 87, 700-709. https://doi.org/10.1002/ana.25702

Bassan, M., Zamostiano, R., Davidson, A., Pinhasov, A., Giladi, E., Perl, O., Bassan, H., Blat, C., Gibney, G., Glazner, G., Brenneman, D. E., & Gozes, I. (1999). Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. Journal of Neurochemistry, 72, 1283-1293. https://doi.org/10.1046/j.1471-4159.1999.0721283.x

Bennison, S. A., Blazejewski, S. M., Liu, X., Hacohen-Kleiman, G., Sragovich, S., Zoidou, S., Touloumi, O., Grigoriadis, N., Gozes, I., & Toyo-oka, K. (2023). The cytoplasmic localization of ADNP through 14-3-3 promotes sex-dependent neuronal morphogenesis, cortical connectivity, and calcium signaling. Molecular Psychiatry. https://doi.org/10.1038/s41380-022-01939-3

Bowles, K. R., Pugh, D. A., Oja, L. M., Jadow, B. M., Farrell, K., Whitney, K., Sharma, A., Cherry, J. D., Raj, T., Pereira, A. C., Crary, J. F., & Goate, A. M. (2022). Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD. Acta Neuropathologica, 143, 225-243. https://doi.org/10.1007/s00401-021-02392-2

Boxer, A. L., Lang, A. E., Grossman, M., Knopman, D. S., Miller, B. L., Schneider, L. S., Doody, R. S., Lees, A., Golbe, L. I., Williams, D. R., Corvol, J. C., Ludolph, A., Burn, D., Lorenzl, S., Litvan, I., Roberson, E. D., Höglinger, G. U., Koestler, M., Jack, C. R., Jr., … AL-108-231 Investigators. (2014). Davunetide in patients with progressive supranuclear palsy: A randomised, double-blind, placebo-controlled phase 2/3 trial. Lancet Neurology, 13, 676-685. https://doi.org/10.1016/S1474-4422(14)70088-2

Brenneman, D. E., & Gozes, I. (1996). A femtomolar-acting neuroprotective peptide. The Journal of Clinical Investigation, 97, 2299-2307. https://doi.org/10.1172/JCI118672

Conrow-Graham, M., Williams, J. B., Martin, J., Zhong, P., Cao, Q., Rein, B., & Yan, Z. (2022). A convergent mechanism of high risk factors ADNP and POGZ in neurodevelopmental disorders. Brain, 145, 3250-3263. https://doi.org/10.1093/brain/awac152

Coughlan, G. T., Betthauser, T. J., Boyle, R., Koscik, R. L., Klinger, H. M., Chibnik, L. B., Jonaitis, E. M., Yau, W. Y. W., Wenzel, A., Christian, B. T., Gleason, C. E., Saelzler, U. G., Properzi, M. J., Schultz, A. P., Hanseeuw, B. J., Manson, J. A. E., Rentz, D. M., Johnson, K. A., Sperling, R., … Buckley, R. F. (2023). Association of age at menopause and hormone therapy use with tau and beta-amyloid positron emission tomography. JAMA Neurology, 80, 462-473. https://doi.org/10.1001/jamaneurol.2023.0455

D'Incal, C. P., Van Rossem, K. E., De Man, K., Konings, A., Van Dijck, A., Rizzuti, L., Vitriolo, A., Testa, G., Gozes, I., Vanden Berghe, W., & Kooy, R. F. (2023). Chromatin remodeler Activity-Dependent Neuroprotective Protein (ADNP) contributes to syndromic autism. Clinical Epigenetics, 15, 45. https://doi.org/10.1186/s13148-023-01450-8

Divinski, I., Holtser-Cochav, M., Vulih-Schultzman, I., Steingart, R. A., & Gozes, I. (2006). Peptide neuroprotection through specific interaction with brain tubulin. Journal of Neurochemistry, 98, 973-984. https://doi.org/10.1111/j.1471-4159.2006.03936.x

Divinski, I., Mittelman, L., & Gozes, I. (2004). A femtomolar acting octapeptide interacts with tubulin and protects astrocytes against zinc intoxication. The Journal of Biological Chemistry, 279, 28531-28538. https://doi.org/10.1074/jbc.M403197200

Doust, Y. V., King, A. E., & Ziebell, J. M. (2021). Implications for microglial sex differences in tau-related neurodegenerative diseases. Neurobiology of Aging, 105, 340-348. https://doi.org/10.1016/j.neurobiolaging.2021.03.010

Elhasnaoui, J., Ferrero, G., Miano, V., Cutrupi, S., & De Bortoli, M. (2021). The estrogen receptor alpha signaling pathway controls alternative splicing in the absence of ligands in breast cancer cells. Cancers, 13, 6261. https://doi.org/10.3390/cancers13246261

Ferreira, A. C. F., Szeto, A. C. H., Clark, P. A., Crisp, A., Kozik, P., Jolin, H. E., & McKenzie, A. N. J. (2023). Neuroprotective protein ADNP-dependent histone remodeling complex promotes T helper 2 immune cell differentiation. Immunity, 56, 1468.e67-1484.e67. https://doi.org/10.1016/j.immuni.2023.05.010

Furman, S., Hill, J. M., Vulih, I., Zaltzman, R., Hauser, J. M., Brenneman, D. E., & Gozes, I. (2005). Sexual dimorphism of activity-dependent neuroprotective protein in the mouse arcuate nucleus. Neuroscience Letters, 373, 73-78. https://doi.org/10.1016/j.neulet.2004.09.077

Furman, S., Steingart, R. A., Mandel, S., Hauser, J. M., Brenneman, D. E., & Gozes, I. (2004). Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes. Neuron Glia Biology, 1, 193-199. https://doi.org/10.1017/S1740925X05000013

Garcia-Gonzalez, P., de Rojas, I., Moreno-Grau, S., Montrreal, L., Puerta, R., Alarcón-Martín, E., Quintela, I., Orellana, A., Andrade, V., Adami, P. V. M., Heilmann-Heimbach, S., Gomez-Garre, P., Periñán, M. T., Alvarez, I., Diez-Fairen, M., Nuñez Llaves, R., Olivé Roig, C., Garcia-Ribas, G., Menéndez-González, M., … Ruiz, A. (2023). Mendelian randomisation confirms the role of Y-chromosome loss in Alzheimer's disease aetiopathogenesis in men. International Journal of Molecular Sciences, 24, 898. https://doi.org/10.3390/ijms24020898

Gozes, I. (2008). VIP, from gene to behavior and back: Summarizing my 25 years of research. Journal of Molecular Neuroscience, 36, 115-124. https://doi.org/10.1007/s12031-008-9105-3

Gozes, I. (2017). Sexual divergence in activity-dependent neuroprotective protein impacting autism, schizophrenia, and Alzheimer's disease. Journal of Neuroscience Research, 95, 652-660. https://doi.org/10.1002/jnr.23808

Gozes, I. (2018). ADNP regulates cognition: A multitasking protein. Frontiers in Neuroscience, 12, 873. https://doi.org/10.3389/fnins.2018.00873

Gozes, I. (2020). The ADNP syndrome and CP201 (NAP) potential and hope. Frontiers in Neurology, 11, 608444. https://doi.org/10.3389/fneur.2020.608444

Gozes, I. (2023). A novel genomic mutation in ADNP leading to intellectual disability. European Journal of Human Genetics, 31, 851-852. https://doi.org/10.1038/s41431-023-01387-9

Gozes, I., Avidor, R., Biegon, A., & Baldino, F., Jr. (1989). Lactation elevates vasoactive intestinal peptide messenger ribonucleic acid in rat suprachiasmatic nucleus. Endocrinology, 124, 181-186. https://doi.org/10.1210/endo-124-1-181

Gozes, I., Bardea, A., Reshef, A., Zamostiano, R., Zhukovsky, S., Rubinraut, S., Fridkin, M., & Brenneman, D. E. (1996). Neuroprotective strategy for Alzheimer disease: Intranasal administration of a fatty neuropeptide. Proceedings of the National Academy of Sciences of the United States of America, 93, 427-432. https://doi.org/10.1073/pnas.93.1.427

Gozes, I., Helsmoortel, C., Vandeweyer, G., Van der Aa, N., Kooy, F., & Bedrosian-Sermone, S. (2015). The compassionate side of neuroscience: Tony sermone's undiagnosed genetic journey-ADNP mutation. Journal of Molecular Neuroscience, 56, 751-757. https://doi.org/10.1007/s12031-015-0586-6

Gozes, I., Ivashko-Pachima, Y., & Sayas, C. L. (2018). ADNP, a microtubule interacting protein, provides neuroprotection through end binding proteins and tau: An amplifier effect. Frontiers in Molecular Neuroscience, 11, 151. https://doi.org/10.3389/fnmol.2018.00151

Gozes, I., & Littauer, U. Z. (1978). Tubulin microheterogeneity increases with rat brain maturation. Nature, 276, 411-413. https://doi.org/10.1038/276411a0

Gozes, I., Patterson, M. C., van Dijck, A., Kooy, R. F., Peeden, J. N., Eichenberger, J. A., Zawacki-Downing, A., & Bedrosian-Sermone, S. (2017). The eight and a half year journey of undiagnosed AD: Gene sequencing and funding of advanced genetic testing has led to hope and new beginnings. Frontiers in Endocrinology, 8, 107. https://doi.org/10.3389/fendo.2017.00107

Gozes, I., Shapira, G., Lobyntseva, A., & Shomron, N. (2023). Surprising sex differences indicate davunetide-mediated brain protection and clinical efficacy in women suffering from progressive supranuclear palsy. Research Square. https://doi.org/10.21203/rs.3.rs-2457393/v1

Gozes, I., & Shazman, S. (2023). A novel davunetide (NAPVSIPQQ to NAPVSIPQE) point mutation in activity-dependent neuroprotective protein (ADNP) causes a mild developmental syndrome. The European Journal of Neuroscience, 58, 2641-2652. https://doi.org/10.1111/ejn.15920

Gozes, I., & Sweadner, K. J. (1981). Multiple tubulin forms are expressed by a single neurone. Nature, 294, 477-480. https://doi.org/10.1038/294477a0

Gozes, I., van Dijck, A., Hacohen-Kleiman, G., Grigg, I., Karmon, G., Giladi, E., Eger, M., Gabet, Y., Pasmanik-Chor, M., Cappuyns, E., Elpeleg, O., Kooy, R. F., & Bedrosian-Sermone, S. (2017). Premature primary tooth eruption in cognitive/motor-delayed ADNP-mutated children. Translational Psychiatry, 7, e1043. https://doi.org/10.1038/tp.2017.27

Gozes, I., Werner, H., Fawzi, M., Abdelatty, A., Shani, Y., Fridkin, M., & Koch, Y. (1989). Estrogen regulation of vasoactive intestinal peptide mRNA in rat hypothalamus. Journal of Molecular Neuroscience, 1, 55-61. https://doi.org/10.1007/BF02896857

Gozes, I., Zaltzman, R., Hauser, J., Brenneman, D., Shohami, E., & Hill, J. (2005). The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury. Current Alzheimer Research, 2, 149-153. https://doi.org/10.2174/1567205053585873

Grigg, I., Ivashko-Pachima, Y., Hait, T. A., Korenková, V., Touloumi, O., Lagoudaki, R., van Dijck, A., Marusic, Z., Anicic, M., Vukovic, J., Kooy, R. F., Grigoriadis, N., & Gozes, I. (2020). Tauopathy in the young autistic brain: Novel biomarker and therapeutic target. Translational Psychiatry, 10, 228. https://doi.org/10.1038/s41398-020-00904-4

Hacohen-Kleiman, G., Sragovich, S., Karmon, G., Gao, A. Y. L., Grigg, I., Pasmanik-Chor, M., le, A., Korenková, V., McKinney, R. A., & Gozes, I. (2018). Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome. The Journal of Clinical Investigation, 128, 4956-4969. https://doi.org/10.1172/JCI98199

Hacohen-Kleiman, G., Yizhar-Barnea, O., Touloumi, O., Lagoudaki, R., Avraham, K. B., Grigoriadis, N., & Gozes, I. (2019). Atypical auditory brainstem response and protein expression aberrations related to ASD and hearing loss in the Adnp haploinsufficient mouse brain. Neurochemical Research, 44, 1494-1507. https://doi.org/10.1007/s11064-019-02723-6

Hadar, A., Kapitansky, O., Ganaiem, M., Sragovich, S., Lobyntseva, A., Giladi, E., Yeheskel, A., Avitan, A., Vatine, G. D., Gurwitz, D., Ivashko-Pachima, Y., & Gozes, I. (2021). Introducing ADNP and SIRT1 as new partners regulating microtubules and histone methylation. Molecular Psychiatry, 26, 6550-6561. https://doi.org/10.1038/s41380-021-01143-9

Helsmoortel, C., Vulto-van Silfhout, A. T., Coe, B. P., Vandeweyer, G., Rooms, L., van den Ende, J., Schuurs-Hoeijmakers, J. H. M., Marcelis, C. L., Willemsen, M. H., Vissers, L. E. L. M., Yntema, H. G., Bakshi, M., Wilson, M., Witherspoon, K. T., Malmgren, H., Nordgren, A., Annerén, G., Fichera, M., Bosco, P., … van der Aa, N. (2014). A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP. Nature Genetics, 46, 380-384. https://doi.org/10.1038/ng.2899

Hofman, M. A., Zhou, J. N., & Swaab, D. F. (1996). Suprachiasmatic nucleus of the human brain: An immunocytochemical and morphometric analysis. The Anatomical Record, 244, 552-562. https://doi.org/10.1002/(SICI)1097-0185(199604)244:4<552::AID-AR13>3.0.CO;2-O

Huang, J., Guo, X., Li, W., & Zhang, H. (2017). Activation of Wnt/beta-catenin signalling via GSK3 inhibitors direct differentiation of human adipose stem cells into functional hepatocytes. Scientific Reports, 7, 40716. https://doi.org/10.1038/srep40716

Ivashko-Pachima, Y., Ganaiem, M., Ben-Horin-Hazak, I., Lobyntseva, A., Bellaiche, N., Fischer, I., Levy, G., Sragovich, S., Karmon, G., Giladi, E., Shazman, S., Barak, B., & Gozes, I. (2022). SH3- and actin-binding domains connect ADNP and SHANK3, revealing a fundamental shared mechanism underlying autism. Molecular Psychiatry, 27, 3316-3327. https://doi.org/10.1038/s41380-022-01603-w

Ivashko-Pachima, Y., & Gozes, I. (2018). NAP protects against tau hyperphosphorylation through GSK3. Current Pharmaceutical Design, 24, 3868-3877. https://doi.org/10.2174/1381612824666181112105954

Ivashko-Pachima, Y., & Gozes, I. (2021). Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy. Progress in Molecular Biology and Translational Science, 177, 65-90. https://doi.org/10.1016/bs.pmbts.2020.07.008

Ivashko-Pachima, Y., Hadar, A., Grigg, I., Korenková, V., Kapitansky, O., Karmon, G., Gershovits, M., Sayas, C. L., Kooy, R. F., Attems, J., Gurwitz, D., & Gozes, I. (2021). Discovery of autism/intellectual disability somatic mutations in Alzheimer's brains: Mutated ADNP cytoskeletal impairments and repair as a case study. Molecular Psychiatry, 26, 1619-1633. https://doi.org/10.1038/s41380-019-0563-5

Ivashko-Pachima, Y., Maor-Nof, M., & Gozes, I. (2019). NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies. PLoS One, 14, e0213666. https://doi.org/10.1371/journal.pone.0213666

Ivashko-Pachima, Y., Sayas, C. L., Malishkevich, A., & Gozes, I. (2017). ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: A novel avenue for protection against tauopathy. Molecular Psychiatry, 22, 1335-1344. https://doi.org/10.1038/mp.2016.255

Ivashko-Pachima, Y., Seroogy, K. B., Sharabi, Y., & Gozes, I. (2021). Parkinson disease-modification encompassing rotenone and 6-hydroxydopamine neurotoxicity by the microtubule-protecting drug candidate SKIP. Journal of Molecular Neuroscience, 71, 1515-1524. https://doi.org/10.1007/s12031-021-01876-w

Javitt, D. C., Buchanan, R. W., Keefe, R. S. E., Kern, R., McMahon, R. P., Green, M. F., Lieberman, J., Goff, D. C., Csernansky, J. G., McEvoy, J. P., Jarskog, F., Seidman, L. J., Gold, J. M., Kimhy, D., Nolan, K. S., Barch, D. S., Ball, M. P., Robinson, J., & Marder, S. R. (2012). Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophrenia Research, 136, 25-31. https://doi.org/10.1016/j.schres.2011.11.001

Jouroukhin, Y., Ostritsky, R., Assaf, Y., Pelled, G., Giladi, E., & Gozes, I. (2013). NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: Protection against impairments in axonal transport. Neurobiology of Disease, 56, 79-94. https://doi.org/10.1016/j.nbd.2013.04.012

Kapitansky, O., & Gozes, I. (2019). ADNP differentially interact with genes/proteins in correlation with aging: A novel marker for muscle aging. Geroscience, 41, 321-340. https://doi.org/10.1007/s11357-019-00079-x

Kapitansky, O., Karmon, G., Sragovich, S., Hadar, A., Shahoha, M., Jaljuli, I., Bikovski, L., Giladi, E., Palovics, R., Iram, T., & Gozes, I. (2020). Single cell ADNP predictive of human muscle disorders: Mouse knockdown results in muscle wasting. Cell, 9, 2320. https://doi.org/10.3390/cells9102320

Kapitansky, O., Sragovich, S., Jaljuli, I., Hadar, A., Giladi, E., & Gozes, I. (2020). Age and sex-dependent ADNP regulation of muscle gene expression is correlated with motor behavior: Possible feedback mechanism with PACAP. International Journal of Molecular Sciences, 21, 6715. https://doi.org/10.3390/ijms21186715

Karmon, G., Sragovich, S., Hacohen-Kleiman, G., Ben-Horin-Hazak, I., Kasparek, P., Schuster, B., Sedlacek, R., Pasmanik-Chor, M., Theotokis, P., Touloumi, O., Zoidou, S., Huang, L., Wu, P. Y., Shi, R., Kapitansky, O., Lobyntseva, A., Giladi, E., Shapira, G., Shomron, N., … Gozes, I. (2022). Novel ADNP syndrome mice reveal dramatic sex-specific peripheral gene expression with brain synaptic and tau pathologies. Biological Psychiatry, 92, 81-95. https://doi.org/10.1016/j.biopsych.2021.09.018

LaCroix, M. S., Mirbaha, H., Shang, P., Zandee, S., Foong, C., Prat, A., White, C. L., III, Stuve, O., & Diamond, M. I. (2022). Tau seeding in cases of multiple sclerosis. Acta Neuropathologica Communications, 10, 146. https://doi.org/10.1186/s40478-022-01444-2

Levine, J., Cohen, D., Herman, C., Verloes, A., Guinchat, V., Diaz, L., Cravero, C., Mandel, A., & Gozes, I. (2019). Developmental phenotype of the rare case of DJ caused by a unique ADNP gene de novo mutation. Journal of Molecular Neuroscience, 68, 321-330. https://doi.org/10.1007/s12031-019-01333-9

Levine, J., Hakim, F., Kooy, R. F., & Gozes, I. (2022). Vineland adaptive behavior scale in a cohort of four ADNP syndrome patients implicates age-dependent developmental delays with increased impact of activities of daily living. Journal of Molecular Neuroscience, 72, 1531-1546. https://doi.org/10.1007/s12031-022-02048-0

Loy, C. J., Sim, K. S., & Yong, E. L. (2003). Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions. Proceedings of the National Academy of Sciences of the United States of America, 100, 4562-4567. https://doi.org/10.1073/pnas.0736237100

Malishkevich, A., Amram, N., Hacohen-Kleiman, G., Magen, I., Giladi, E., & Gozes, I. (2015). Activity-dependent neuroprotective protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer's pathologies. Translational Psychiatry, 5, e501. https://doi.org/10.1038/tp.2014.138

Malishkevich, A., Marshall, G. A., Schultz, A. P., Sperling, R. A., Aharon-Peretz, J., & Gozes, I. (2016). Blood-borne activity-dependent neuroprotective protein (ADNP) is correlated with premorbid intelligence, clinical stage, and Alzheimer's disease biomarkers. Journal of Alzheimer's Disease, 50, 249-260. https://doi.org/10.3233/JAD-150799

Mandel, S., & Gozes, I. (2007). Activity-dependent neuroprotective protein constitutes a novel element in the SWI/SNF chromatin remodeling complex. The Journal of Biological Chemistry, 282, 34448-34456. https://doi.org/10.1074/jbc.M704756200

Mandel, S., Rechavi, G., & Gozes, I. (2007). Activity-dependent neuroprotective protein (ADNP) differentially interacts with chromatin to regulate genes essential for embryogenesis. Developmental Biology, 303, 814-824. https://doi.org/10.1016/j.ydbio.2006.11.039

Marriott, R. J., Murray, K., Flicker, L., Hankey, G. J., Matsumoto, A. M., Dwivedi, G., Antonio, L., Almeida, O. P., Bhasin, S., Dobs, A. S., Handelsman, D. J., Haring, R., O'Neill, T. W., Ohlsson, C., Orwoll, E. S., Vanderschueren, D., Wittert, G. A., Wu, F. C. W., & Yeap, B. B. (2022). Lower serum testosterone concentrations are associated with a higher incidence of dementia in men: The UK Biobank prospective cohort study. Alzheimers Dement, 18, 1907-1918. https://doi.org/10.1002/alz.12529

Merenlender-Wagner, A., Malishkevich, A., Shemer, Z., Udawela, M., Gibbons, A., Scarr, E., Dean, B., Levine, J., Agam, G., & Gozes, I. (2015). Autophagy has a key role in the pathophysiology of schizophrenia. Molecular Psychiatry, 20, 126-132. https://doi.org/10.1038/mp.2013.174

Merenlender-Wagner, A., Shemer, Z., Touloumi, O., Lagoudaki, R., Giladi, E., Andrieux, A., Grigoriadis, N. C., & Gozes, I. (2014). New horizons in schizophrenia treatment: Autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia. Autophagy, 10, 2324-2332. https://doi.org/10.4161/15548627.2014.984274

Morimoto, B. H., Schmechel, D., Hirman, J., Blackwell, A., Keith, J., Gold, M., & on behalf of the AL-108-211 Study Investigators. (2013). A double-blind, placebo-controlled, ascending-dose, randomized study to evaluate the safety, tolerability and effects on cognition of AL-108 after 12 weeks of intranasal administration in subjects with mild cognitive impairment. Dementia and Geriatric Cognitive Disorders, 35, 325-336. https://doi.org/10.1159/000348347

Oz, S., Ivashko-Pachima, Y., & Gozes, I. (2012). The ADNP derived peptide, NAP modulates the tubulin pool: Implication for neurotrophic and neuroprotective activities. PLoS One, 7, e51458. https://doi.org/10.1371/journal.pone.0051458

Oz, S., Kapitansky, O., Ivashco-Pachima, Y., Malishkevich, A., Giladi, E., Skalka, N., Rosin-Arbesfeld, R., Mittelman, L., Segev, O., Hirsch, J. A., & Gozes, I. (2014). The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins. Molecular Psychiatry, 19, 1115-1124. https://doi.org/10.1038/mp.2014.97

Pinhasov, A., Mandel, S., Torchinsky, A., Giladi, E., Pittel, Z., Goldsweig, A. M., Servoss, S. J., Brenneman, D. E., & Gozes, I. (2003). Activity-dependent neuroprotective protein: A novel gene essential for brain formation. Developmental Brain Research, 144, 83-90. https://doi.org/10.1016/s0165-3806(03)00162-7

Quraishe, S., Cowan, C. M., & Mudher, A. (2013). NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy. Molecular Psychiatry, 18, 834-842. https://doi.org/10.1038/mp.2013.32

Roethler, O., Zohar, E., Cohen-Kashi Malina, K., Bitan, L., Gabel, H. W., & Spiegel, I. (2023). Single genomic enhancers drive experience-dependent GABAergic plasticity to maintain sensory processing in the adult cortex. Neuron. https://doi.org/10.1016/j.neuron.2023.05.026

Schirer, Y., Malishkevich, A., Ophir, Y., Lewis, J., Giladi, E., & Gozes, I. (2014). Novel marker for the onset of frontotemporal dementia: Early increase in activity-dependent neuroprotective protein (ADNP) in the face of Tau mutation. PLoS One, 9, e87383. https://doi.org/10.1371/journal.pone.0087383

Schwabenland, M., Mossad, O., Sievert, A., Peres, A. G., Ringel, E., Baasch, S., Kolter, J., Cascone, G., Dokalis, N., Vlachos, A., Ruzsics, Z., Henneke, P., Prinz, M., & Blank, T. (2023). Neonatal immune challenge poses a sex-specific risk for epigenetic microglial reprogramming and behavioral impairment. Nature Communications, 14, 2721. https://doi.org/10.1038/s41467-023-38373-0

Sragovich, S., Merenlender-Wagner, A., & Gozes, I. (2017). ADNP plays a key role in autophagy: From autism to schizophrenia and Alzheimer's disease. BioEssays, 39. https://doi.org/10.1002/bies.201700054

Sragovich, S., Ziv, Y., Vaisvaser, S., Shomron, N., Hendler, T., & Gozes, I. (2019). The autism-mutated ADNP plays a key role in stress response. Translational Psychiatry, 9, 235. https://doi.org/10.1038/s41398-019-0569-4

Sudo, H., & Baas, P. W. (2011). Strategies for diminishing katanin-based loss of microtubules in tauopathic neurodegenerative diseases. Human Molecular Genetics, 20, 763-778. https://doi.org/10.1093/hmg/ddq521

Sun, X., Peng, X., Cao, Y., Zhou, Y., & Sun, Y. (2020). ADNP promotes neural differentiation by modulating Wnt/beta-catenin signaling. Nature Communications, 11, 2984. https://doi.org/10.1038/s41467-020-16799-0

Tsujikawa, K., Hamanaka, K., Riku, Y., Hattori, Y., Hara, N., Iguchi, Y., Ishigaki, S., Hashizume, A., Miyatake, S., Mitsuhashi, S., Miyazaki, Y., Kataoka, M., Jiayi, L., Yasui, K., Kuru, S., Koike, H., Kobayashi, K., Sahara, N., Ozaki, N., … Katsuno, M. (2022). Actin-binding protein filamin-A drives tau aggregation and contributes to progressive supranuclear palsy pathology. Science Advances, 8, eabm5029. https://doi.org/10.1126/sciadv.abm5029

Van Dijck, A., Vulto-van Silfhout, A. T., Cappuyns, E., van der Werf, I. M., Mancini, G. M., Tzschach, A., Bernier, R., Gozes, I., Eichler, E. E., Romano, C., Lindstrand, A., Nordgren, A., ADNP Consortium, Kvarnung, M., Kleefstra, T., de Vries, B. B. A., Küry, S., Rosenfeld, J. A., Meuwissen, M. E., … Kooy, R. F. (2019). Clinical presentation of a complex neurodevelopmental disorder caused by mutations in ADNP. Biological Psychiatry, 85, 287-297. https://doi.org/10.1016/j.biopsych.2018.02.1173

Vulih-Shultzman, I., Pinhasov, A., Mandel, S., Grigoriadis, N., Touloumi, O., Pittel, Z., & Gozes, I. (2007). Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model. The Journal of Pharmacology and Experimental Therapeutics, 323, 438-449. https://doi.org/10.1124/jpet.107.129551

Yan, Y., Wang, X., Chaput, D., Shin, M. K., Koh, Y., Gan, L., Pieper, A. A., Woo, J. A. A., & Kang, D. E. (2022). X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women. Cell, 185, 3913.e19-3930.e19. https://doi.org/10.1016/j.cell.2022.09.002

Yang, Y., Liang, F., Gao, J., Dong, Y., Zhang, Y., Yang, G., Soriano, S. G., Feng, H. J., & Xie, Z. (2021). Testosterone attenuates sevoflurane-induced tau phosphorylation and cognitive impairment in neonatal male mice. British Journal of Anaesthesia, 127, 929-941. https://doi.org/10.1016/j.bja.2021.08.028

Zamostiano, R., Pinhasov, A., Gelber, E., Steingart, R. A., Seroussi, E., Giladi, E., Bassan, M., Wollman, Y., Eyre, H. J., Mulley, J. C., Brenneman, D. E., & Gozes, I. (2001). Cloning and characterization of the human activity-dependent neuroprotective protein. The Journal of Biological Chemistry, 276, 708-714. https://doi.org/10.1074/jbc.M007416200

Zhou, J. N., Hofman, M. A., & Swaab, D. F. (1995). VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease. Neurobiology of Aging, 16, 571-576. https://doi.org/10.1016/0197-4580(95)00043-e

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Subventions

Informations de copyright

Références

Auteurs

Illana Gozes (I)

Classifications MeSH